Next Article in Journal
Optimization of Protoplast Preparation and Establishment of PEG-Mediated Genetic Transformation Method in Cordyceps cicadae
Previous Article in Journal
Epidemiology and Clinical Features of Candida Bloodstream Infections: A 10-Year Retrospective Study in a Korean Teaching Hospital
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Epidemiological Profile of Otomycosis at the Peace Hospital of Ziguinchor (Senegal)

1
Health Science Training and Research Unit, Assane SECK University of Ziguinchor, Ziguinchor 27000, Senegal
2
PEACE Hospital of Ziguinchor, Ziguinchor 27000, Senegal
3
Ziguinchor Regional Hospital Center, Ziguinchor 27000, Senegal
4
Service of Parasitology-Mycology, Faculty of Medicine, Pharmacy and Odontology, Cheikh Anta Diop University, Dakar 16477, Senegal
*
Author to whom correspondence should be addressed.
J. Fungi 2025, 11(3), 218; https://doi.org/10.3390/jof11030218
Submission received: 7 December 2024 / Revised: 25 January 2025 / Accepted: 10 February 2025 / Published: 12 March 2025

Abstract

:
The investigation of the fungal etiologies of otomycoses is a rare occurrence in Senegal. The present study aspires to ascertain the profile of these mycoses within the confines of Ziguinchor. Conducted from 3 February 2021 to 31 August 2022, this retrospective descriptive study encompassed a total of 82 patients presenting with clinically suspected otomycosis within the otolaryngology (ENT) department of the Ziguinchor Peace Hospital (ZPH). In this study, two samples were collected from the external auditory canal (EAC) of each patient using sterile swabs. These samples were first observed by direct microscopy and then cultured at 30 °C on Sabouraud chloramphenicol with or without cycloheximide. The identification of the isolates was based on their macroscopic, microscopic, and physiological characteristics. The mycological examination was positive in 70 patients, with a prevalence of 85.37%. The most prevalent fungal isolates were Aspergillus section Nigri (30%), Aspergillus section Flavi (20%), and Candida albicans/Candida dubliniensis (10%). Of the clinical signs examined, auricular pruritus (p = 1.7033 × 10−6) was the only one to demonstrate a positive correlation with the onset of otomycosis. These results indicate that fungal agents play a significant role in the pathogenesis of otitis externa, underscoring the importance of mycological diagnosis in ensuring optimal patient management.

1. Introduction

Otomycoses are ear infections caused by microscopic fungi, which develop mainly in the external auditory canal (EAC). According to recent studies, otomycosis represents 5 to 10% of all cases of otitis externa [1,2,3]. The most likely factors causing otomycosis are heat, humidity, poor personal hygiene, bathing or diving in cold water or seawater, and topical antibiotics [2,4,5,6].
The incidence of these infections has increased in recent years due to the widespread use of antibiotics to treat bacterial ear infections, as well as other factors linked to weakened immunity [2]. The most commonly encountered agents are species belonging to the Aspergillus and Candida genera [2,7].
The relative frequency of etiological agents can vary depending on geographical factors [2,8]. Otomycosis emerges frequently in tropical and subtropical zones, where it is unfortunately often confused with chronic otitis media because of its association with common germs. In Senegal, there are very few studies on otomycosis, and those existing are limited to the Dakar region. Consequently, prescribing physicians must address the challenge of selecting an appropriate therapeutic plan due to the diverse polymorphism of fungal agents implicated in otomycosis. In order to optimize the choice of antifungal medication and significantly reduce the risk of serious complications, it is first necessary to determine the pathogens responsible for otomycosis. The present work, therefore, aims to determine the prevalence of otomycosis in the region of Ziguinchor (Senegal), to identify the etiological agents and the factors likely to be associated with its occurrence.

2. Materials and Methods

This is a retrospective study with descriptive and analytical aims. The study encompassed all patient files received for ear sample testing from 3 February 2021, to 31 August 2022. The objective was to make a mycological diagnosis of otomycosis, with meticulous record-keeping. The studied data were obtained from a database recorded in the laboratory’s dedicated register, and from otomycosis sample reception forms. Missing data were filled-in from otomycosis sample forms and patient files held in the otorhinolaryngology (ENT) department of the Ziguinchor Peace Hospital.
During the study period, the mycological diagnosis of otomycoses was based on swab samples taken from the otorhinolaryngology (ENT) department of the Ziguinchor Peace Hospital followed by the mycological examination of the said samples by the laboratory of the Ziguinchor Regional Hospital Center (ZRHC).
Samples were collected by an ENT physician before any administration of antifungal agents in all patients with clinically suspected otomycosis. The EAC was first cleaned with a sterile cotton swab (Deltalab Barcelona Spain) soaked in 0.9% NaCl (Laboratoires Physiodose Gilbert Caen France). Ear samples were obtained either under a headlamp or an otomicroscope, using two sterile swabs soaked in 5 mL of 0.9% NaCl (Laboratoires physiodose Caen France). After collection, each sample was promptly placed in a plastic bag and securely sealed, then handed over to the patient, who transported it at room temperature within 20 min to the laboratory of the laboratory of the Ziguinchor Regional Hospital Center (ZRHC).
For each sample collected, a mycological examination was conducted immediately after reception in the following stages:
A direct microscopic examination of one of the two swabs was performed in a drop of saline solution. To do this, 500 µL of saline was added to the swab, which was vortexed. Then, 70 µL of the vortexed sample was used for direct slide-to-slide examination, which was observed with 10× and then 40× objectives.
The inoculation of the remaining swab onto Sabouraud Chloramphenicol (SC) HIMEDIA® agar (HIMEDIA Laboratories, Mumbai, India) and Sabouraud Chloramphenicol Cycloheximide) HIMEDIA® agar (HIMEDIA Laboratories, Mumbai, India).
The remaining swab was then inoculated onto Sabouraud Chloramphenicol (SC) HIMEDIA® agar (HIMEDIA Laboratories, Mumbai, India) and Sabouraud Chloramphenicol Cycloheximide) HIMEDIA® agar (HIMEDIA Laboratories, Mumbai, India). The inoculation process was adapted according to the nature of the sample. Samples with visible solid elements were collected with a loop, placed in a Petri dish, and cut with a scalpel blade. The cut-out pieces were then spot-applied to SC (HIMEDIA Laboratories, Mumbai, India) and SCA (HIMEDIA Laboratories, Mumbai, India) agars. For other samples, the swab was directly inoculated using the quadrant method on SC (HIMEDIA Laboratories, Mumbai, India) medium, followed by SCA (HIMEDIA Laboratories, Mumbai, India). The previously inoculated agar media (SC and SCA) were then incubated in a proofer at 30 °C with 5% CO2 in a humidified atmosphere and observed daily for one to two weeks.
Identification of the pathogen was based on macroscopic (colony characteristics, appearance, and color) and microscopic criteria for filamentous fungi (thallus appearance, hyphal color, shape, spore morphology, and conidiogenesis) [9]. Yeasts were also identified based on the following criteria:
On a macroscopic level, the distinguishing features of the two yeast types are as follows: Candida yeasts manifest as white, shiny or matte, smooth or wrinkled colonies with no visible pigmentation, while Cryptococcus yeasts are beige, smooth, runny, or shiny.
Microscopic: In the case of the Candida genus, we observe oval blastopores with unipolar budding, measuring between 2 and 10 µm in length. These blastopores may or may not be accompanied by mycelium or pseudo-mycelium. In contrast, the Cryptococcus genus features globular blastospores with multipolar budding, ranging from 2 to 12 µm in diameter. These blastospores may also be associated with a capsule and the absence of mycelial filaments.
In the context of susceptibility and/or resistance to cycloheximide, the presence of growth on SCA agar previously incubated at 30 °C was sufficient to indicate that a species was resistant to cycloheximide. For yeasts, this was oriented towards certain species, including Candida albicans/Candida dubliniensis.
The Blastèse test is a method used to identify the presence of Candida albicans/Candida dubliniensis. The test is performed by adding one drop of yeast suspension to 1 mL of fresh human serum and incubating it at 37 °C for three hours. The presence of germ tubes indicates the presence of either Candida albicans or Candida dubliniensis.
India ink test: the first step is to apply 25 µL of India ink to an object slide, then adding 75 µL of 0.9% NaCl (physiodose Laboratoire Caen France) and a small portion of the colony. The next step is covering it with a coverslip to be read under the microscope at 40× objective. The presence of a capsule indicates the presence of Cryptococcus and excludes Candida.
Urease test: A whole colony isolated on SC medium is placed in a tube containing Bio-Rad urea-indole broth (Laboratoire Bio-Rad, Paris, France). This is incubated at 37 °C for 4 h. A positive test result is indicated by the medium turning purplish-red, confirming the genus Cryptococcus, and invalidating the diagnosis of Cryptococcus sp. [10].
The data collected were entered into Excel 2013 and analyzed using R software (R Core Team, R Foundation for Statistical Computing, Vienna, Austria (2022)). Variables such as sociodemographic (age, sex, geographic origin, etc.), clinical (history and clinical signs), and mycological (direct examination, isolated species) variables were analyzed for each patient. Data were described in terms of mean or percentage, with quantitative or qualitative variables. The prevalence rates were calculated overall and also according to age, sex symptoms, and contributing factors. Pearson’s χ2 test at the 5% significance level and Fisher’s exact test, when the numbers are less than 5, were used to compare the proportions.

3. Results

3.1. Characteristics of the Study Population

During the study period, 82 patients underwent mycological examination; their ages ranged from 7 months to 79 years, with a mean age of 37.81. The majority of patients were over 21 years of age, amounting to 78.04% of the study population, while 16 patients were under 20 years of age, representing 19.51% of the total (see Table 1). Females accounted for 53.66% of the study population, giving a sex ratio of 0.86.

3.2. Otomycosis: Prevalences and Frequencies Depending on the Variables Studied

Of the 82 samples taken, the mycology cultures were positive on 70 occasions, representing a prevalence rate of 85.37%, including three negative samples using direct examination. Two samples were positive using direct examination and turned out negative on culture. The culture allowed the isolation of 82 strains, including 67.07% molds (55 strains) and 32.93% yeasts (27 strains). The fungal agents most frequently encountered were Aspergillus section Nigri in 30% (21/70) of cases, Aspergillus section Flavi in 20% of cases, Candida albicans/Candida dubliniensis in 10% of cases, and Candida sp. in 10% of cases. In 12 cases (17.14%), the associations between two fungal species were noted, with the association between Aspergillus section Nigri + Candida sp. (7.14%) and that of Aspergillus section Flavi + Candida sp. (4.28%) (Table 2) being prominent.
Based on data from 70 positive cases, the prevalence of otomycosis was virtually identical in males and females (86.84% vs. 84.09%), with a p-value of 0.7252 (see Table 1). Thus, there was no significant difference in the incidence of otomycosis according to sex. Regarding age, the prevalence of otomycosis was 90.90%, 81.25%, and 80.65% in those aged 21–40, 0–20, and over 40 years, respectively, with a p-value of 0.9363 (see Table 1). Thus, there was no significant difference in the incidence of otomycosis according to age.
Clinically, the infection was unilateral for 80% of cases (right ear 47% and left ear 33%) and bilateral for 20% of cases. Regarding the symptoms associated with the infection, they were specified for 87% (61/70) of the patients. The predominant symptoms were ear pruritus (72.86%), otalgia (60%), hearing loss (40%), otorrhoea (21.43%), and tinnitus (20%). Other symptoms, such as fever (4.29%), autophony (1.43%), and headache (1.43%), were less frequent in patients with otomycosis (Table 2). Similarly, the main lifestyle-related factors found in otomycosis were the improper cleaning of ears (36 out of 70 patients or 51.43%), humidity (25.71%), wearing headphones (15.71%), swimming (8.57%), and the presence of foreign bodies in the EAC (7.14%). Other factors linked to patients’ medical history were also highlighted in 40 cases. These were mainly allergies (20%), taking local antibiotics (15.71%), diabetes (5.71%), and ear trauma (4.29%). Other medical factors such as HIV infection, prolonged corticosteroid therapy, otologic surgery, and traditional medicine were found with a frequency of 2.86% each (Table 3).
The analysis of the parameters does not highlight an association between sex (p = 0.7252), age (p = 0.9363), lifestyle (p = 0.382), medical history (p = 0.9645), certain clinical signs (ear pain, hypoacusia, tinnitus, fever, and headache…) and the occurrence of otomycosis. Furthermore, otomycosis was significantly correlated with auricular pruritus (p=1.7033 × 10−6).

4. Discussion

Mycological diagnosis is vital in curing otomycosis, as it helps guide the choice of treatment. A retrospective descriptive study was conducted at the Ziguinchor Peace Hospital, examining all patients with clinically suspected otomycosis during the study period. An ENT doctor took samples before the administration of antifungal agents. The survey revealed a prevalence of 85.37% for this disease, which is usually overlooked in everyday practice. The significance of mycological diagnosis in establishing a reliable diagnosis of this mycosis is now well established.
The high prevalence of 85.37% found in our study is comparable to that found by certain authors in Africa (80% in Côte d’Ivoire, 74.2% in Egypt) and in Asia (82% to 92% in Iran, 70% in Turkey, 78% in India) [7,11,12,13,14,15]. These data show that fungal infections occupy an important place in the etiologies of otitis externa. Conversely, lower prevalences have also been noted by other authors, such as 56.6% found in Senegal itself, 12.53% in Niger, 42.8% in Côte d’Ivoire, 50.5% in Iran in 2022, 19.4% in Brazil, and 28.4% in Spain [2,3,16,17,18]. The difference in prevalence observed in Senegal between our study and that of Dieng T et al. could be explained by several factors. Firstly, different climatic and weather conditions between Ziguinchor and Dakar could be a contributing factor. Secondly, most of our patients presented either medical history and/or lifestyle habits (promoting factors) that could favor the occurrence of otomycosis. The high prevalence observed in Senegal and other African countries, such as Côte d’Ivoire [7], can be explained by the combination of certain factors: the climate (humidity and heat), certain religious, cultural, or aesthetic practices that lead to maintaining a wet external auditory canal (ablutions, wearing a scarf or veil, and long locks braided with synthetic or real hair by women).
Fungal culture enabled the isolation of 82 strains of molds and yeasts, with a predominance of molds (67.07%). The dominant species were Aspergillus section Nigri, followed by Aspergillus section Flavi, and the Candida albicans/Candida dubliniensis complex. In addition to the aforementioned species, other types of the Candida genus were also frequently isolated; however, due to a paucity of resources, we were unable to identify them at the species level. However, such identification would provide a more accurate understanding of the fungi responsible for otomycosis in Ziguinchor. This would facilitate more effective infection management by determining the most efficacious antifungal agents. This represents a significant limitation of the present study.
This result is similar to that of Roohi B et al. in Iran who found that the dominant species was Aspergillus section Nigri (58.57%), followed by Aspergillus section Flavi (19.23%), and finally the species Candida parapsilosis (14.96%) [17]. Our result is different from that of Dieng T et al. in Senegal, which highlighted Candida albicans and Aspergillus section Fumigati as co-dominant species (26.30% each), followed by Aspergillus section Nigri (22.80%) and Candida sp. (12.30%) [2]. The distribution of species varies from one country to another, from one region to another. Thus, in Côte d’Ivoire, the main agents of otomycoses found by Bosson-Vanga H et al. are Candida albicans, Aspergillus section Flavi and Candida parapsilosis [16]. Just as in Poland, Kurnatowski et al. found a predominance of species of the genus Candida, particularly Candida parapsilosis (29.3%), Candida albicans (19.0%) and Aspergillus section Nigri (14.7%); however, a predominance of candida was reported by Pontes ZB, with C. albicans (30%), C. parapsilosis (20%) and Aspergillus section Nigri (20%). The results of Amrin K et al. in India highlighted a predominance of Aspergillus, with Aspergillus section Nigri at 43.73% and Candida sp. at 35.2%, and Aspergillus section Fumigati (1.06%) [18,19,20].
Regarding the microscopic examination, we found two positive samples on direct examination that were negative on culture. The reason for this may be that some of our patients were taking traditional medicines with known antifungal properties, which could have led to the elimination of the infection.
In our study and those of Adoubryn et al. [7] and Djohan et al. [21], neither sex nor age predicted otomycosis. In contrast to Ali et al. and Aboulmakarim et al., who found a predominance of females and a higher incidence in people aged between 21 and 40 years [22,23], Nwabuisi et al. found an equality between males and females [24] and Abdelazeem et al. found a predominance of males with a higher incidence in people aged between 21 and 40 years [25]. The incidence of otomycosis as a function of age and sex varies from study to study and is the source of much controversy.
In the present study, the most frequently cited factors related to otomycosis were determined to be improper ear cleaning (51.43%), humidity (25.71%), wearing headphones (15.71%), bathing (8.57%), and the presence of cotton in the CAE (7.14%). However, no significant association was identified between these factors and the occurrence of otomycosis. As emphasized in our study, the primary factor promoting otomycosis is the untimely cleaning of the ear with a cotton bud, as evidenced by the work of Djafarou AB et al. [3] in Niger (53.57%) and Abdoumakarim S et al. [23] in Morocco (56.4%). The utilization of poultry feathers for ear cleaning has been identified as a risk factor for otomycosis, attributable to the prevalence of avian aspergillosis in these animals. Conversely, a study by Garcia-Martos et al. in Spain demonstrated that swimming (90%) was the predominant risk factor for otomycosis [26]. Vennewald et al. also state that the risk of contracting otomycosis is five times higher in swimmers than in non-swimmers [27]. Medical history including allergies, otological surgery, and/or ear trauma was frequently found, although none of these were significantly associated with the occurrence of otomycosis. This result is consistent with several other studies [7,28,29,30].
According to the results of our study, the primary symptoms were primarily ear pruritus (72.86%), followed by otalgia (60.00%) and hypoacusis (40.00%). Statistically, auricular pruritus has been demonstrated to be associated with the onset of otomycosis. Similar results have been demonstrated by several authors, although differences in frequency have been noted [2,28,29].
Despite the inherent limitations of the study, including the unavailability of equipment and resources necessary for the more precise identification of the species and assessment of antifungal resistance, the study’s primary objective was successful. This objective was to determine the prevalence of otomycosis in the Ziguinchor region of Senegal, identify the underlying etiological agents, and determine the factors associated with its occurrence.

5. Conclusions

The survey revealed a relatively high prevalence of otomycosis cases in the southern region of Senegal. Given the predominance of the genera Aspergillus and Candida as etiological agents in otitis media, there is a need for mycological diagnosis in cases of otitis media to avoid the excessive use of antibiotics. It is important to carry out prevalence surveys on larger samples to better assess the impact of these fungal pathologies and the risks they represent.

Author Contributions

Conceptualization, A.D., H.Y. and P.S.D.; methodology, H.Y.; software, A.D.; validation, K.D. (Kalilou Diallo), Y.S., K.D. (Khadim Diongue), M.N., M.N.C. and H.S.; formal analysis, A.D.; investigation P.S.D.; resources A.D.; data conservation P.S.D.; writing—preparation of original version, A.D.; writing—reading and editing H.Y.; supervision E.S.D. and D.N.; project administration, D.N.; acquisition of funds, A.D. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The necessity for ethical review and approval was deemed non-applicable to this study, on the grounds that it constituted a retrospective study. Furthermore, the utilisation of human samples was precluded, as the study incorporated the utilisation of collective data. The inherent nature of this data precluded the identification of any individual or the undermining of individual honour or privacy.

Informed Consent Statement

Not applicable.

Data Availability Statement

For reasons of confidentiality and ethics, these data are not accessible. However, if necessary, these data can be provided in part, provided that the non-disclosure of these data and respect for confidentiality can be guaranteed.

Acknowledgments

We thank all the partners who helped us carry out this study, namely: The laboratory of the regional hospital center of Ziguinchor, Senegal; The ENT department of the Peace Hospital of Ziguinchor, Senegal; The Health Department of Assane Seck University in Ziguinchor, Senegal; International Center for Research and Training in Applied Genomics and Health Surveillance. Dakar, Senegal.

Conflicts of Interest

The authors declare that there are no conflicts of interest.

References

  1. Saniasiay, J.; Salim, R.; Mohamad, I.; Harun, A. Antifungal Effect of Malaysian Aloe vera Leaf Extract on Selected Fungal Species of Pathogenic Otomycosis Species in In Vitro Culture Medium. Oman Med. J. 2017, 32, 41–46. [Google Scholar] [CrossRef] [PubMed]
  2. Dieng, T. Otomycosis at Fann Hospital in Dakar (Senegal): Prevalence and Mycological Study. Open Access J. Mycol. Mycol. Sci. 2020, 3, 000129. [Google Scholar] [CrossRef]
  3. Djafarou, A.; Djangnikpo, M.; Salaou, C.; Hamza, A.; Amadou, I.; Illé, S. Profil Épidémiologique et Mycologique de l’Otomycose à l’Hôpital Général de Référence de Niamey (Niger). Health Sci. Dis. 2022, 23, 38–40. [Google Scholar]
  4. Javidnia, J.; Ghotbi, Z.; Ghojoghi, A.; Solhjoo, K.; Alshahni, M.M.; Jeddi, S.A.; Ahmadi, B.; Nouripour-Sisakht, S.; Ansari, S.; Shokoohi, G. Otomycosis in the South of Iran with a High Prevalence of Tympanic Membrane Perforation: A Hospital-Based Study. Mycopathologia 2022, 187, 225–233. [Google Scholar] [CrossRef]
  5. Khasanov, U.S. Features of Mycological and Clinical Studies of Otomycosis. Am. J. Med. Sci. Pharm. Res. 2022, 4, 40–59. [Google Scholar] [CrossRef]
  6. Prasad, S.C.; Kotigadde, S.; Shekhar, M.; Thada, N.D.; Prabhu, P.; Souza, T.D.; Prasad, K.C. Primary Otomycosis in the Indian Subcontinent: Predisposing Factors, Microbiology, and Classification. Int. J. Microbiol. 2014, 2014, 636493. [Google Scholar] [CrossRef]
  7. Adoubryn, K.D.; N’Gattia, V.K.; Kouadio-Yapo, G.C.; Nigue, L.; Zika, D.K.; Ouhon, J. Epidemiology of otomycoses at the university hospital of Yopougon (Abidjan-Ivory Coast). J. Mycol. Medicale 2014, 24, e9–e15. [Google Scholar] [CrossRef]
  8. Li, Y.; He, L. Diagnosis and treatment of otomycosis in southern China. Mycoses 2019, 62, 1064–1068. [Google Scholar] [CrossRef]
  9. Chabasse, D.; Bouchara, J.P.; De Gentile, L.; Brun, S.; Cimon, B.; Penn, P. Les Moisissures d’Interet Medical; Cahier de Formation N °25; Bioforma: Paris, France, 2002; p. 160. [Google Scholar]
  10. Bouchara, J.-P.; Pihet, M.; de Gentile, L.; Cimon, B.; Chabasse, D. Les Levures et Levuroses—Cahier de Formation, Biologie Médicale; Bioforma: Paris, France, 2010; Volume 44, 200p. [Google Scholar]
  11. Moharram, A.M.; Ahmed, H.E.; Salma, A.M.N. Otomycosis in Assiut, Egypt. J. Basic Appl. Mycol. (Egypt) 2013, 4, 1–11. [Google Scholar]
  12. Nazeer, H.; Mohiddin, S.; Pakanati, S. Mycology of Otomycosis in a Tertiary Care Teaching Hospital. J. Res. Med. Dent. Sci. 2015, 3, 27. [Google Scholar] [CrossRef]
  13. Değerli, K.; Ecemiş, T.; Günhan, K.; Başkesen, T.; Kal, E. Agents of otomycosis in Manisa region, Turkey, 1995–2011. Mikrobiyoloji Bul. 2012, 46, 79–84. [Google Scholar]
  14. Aneja, K.; Sharma, C.; Joshi, R. Fungal infection of the ear: A common problem in the north eastern part of Haryana. Int. J. Pediatr. Otorhinolaryngol. 2010, 74, 604–607. [Google Scholar] [CrossRef]
  15. Kazemi, A.; Majidinia, M.; Jaafari, A.; Mousavi, S.A.A.; Mahmoudabadi, A.Z.; Alikhah, H. Etiologic Agents of Otomycosis in the North-Western Area of Iran. Jundishapur J. Microbiol. 2015, 8, e21776. [Google Scholar] [CrossRef] [PubMed]
  16. Angora, K.E.; Miezan, S.A.J.; N’guiachi, M.A.; Ouattara, M.; Bédia-Tanoh, V.A.; Koné, E.M.; Kiki-Barro, P.C.; Kassi, F.K.; Vanga-Bosson, H.; Konaté-Touré, A.; et al. Profil des otomycoses diagnostiquées à l’Institut Pasteur de Côte d’Ivoire. Rev. Int. Sci. Médicales 2018, 3, 207–212. [Google Scholar]
  17. Roohi, B.; Nemati, S.; Alipour, A.; Faeli, L.; Mayahi, S.; Haghani, I.; Shalchizadeh, M.; Darini, A.; Al-Hatmi, A.M.S.; Abastabar, M.; et al. Otomycosis: The foremost etiological agent causing otitis externa and the antifungal susceptibility pattern in north-western Iran. Mycoses 2022, 66, 87–97. [Google Scholar] [CrossRef]
  18. Pontes, Z.B.V.d.S.; Silva, A.D.F.; Lima, E.d.O.; Guerra, M.d.H.; Oliveira, N.M.C.; Carvalho, M.d.F.F.P.; Guerra, F.S.Q. Otomycosis: A retrospective study. Braz. J. Otorhinolaryngol. 2009, 75, 367–370. [Google Scholar] [CrossRef] [PubMed]
  19. Amrin, K.; Sudhir, K. Occurrence of fungi causes otomycosis in rural areas of MP, India. Int. Res. J. Biol. Sci. 2021, 10, 210–220. [Google Scholar]
  20. Kurnatowski, P.; Filipiak, A. Otomycosis: Prevalence, clinical symptoms, therapeutic procedure. Mycoses 2001, 44, 472–479. [Google Scholar] [CrossRef]
  21. Djohan, V.; Vanga-Bosson, H.A.; Yavo, W.; Kiki-Barro, P.M.C.; Konate, A.; Kassi, F.K. Prévalence et facteurs de risque des otomycoses à Abidjan (Côte d’Ivoire). Eur. J. Sci. Res. 2010, 40, 232–238. [Google Scholar]
  22. Ali, K.; Hamed, M.A.; Hassan, H.; Esmail, A.; Sheneef, A. Identification des agents pathogènes fongiques dans l’otomycose et leur sensibilité aux médicaments: Notre expérience. Int. Arch. Otorhinolaryngol. 2018, 22, 400–403. [Google Scholar]
  23. Aboulmakarim, S.; Tligui, H.; Mrini, M.; El Zakaria, I.; Handour, N.; Agoumi, A. Otomycoses: Étude clinique et mycologique de 70 cas. J. Mycol. Médicale 2010, 20, 48–52. [Google Scholar] [CrossRef]
  24. Nwabuisi, C.; Ologe, F.E. The fungal profile of otomycosis patients in Ilorin, Nigeria. Niger. J. Med. 2001, 10, 124–126. [Google Scholar]
  25. Abdelazeem, M.; Gamea, A.; Mubarak, H.; Elzawawy, N. Épidémiologie, agents étiologiques et facteurs de risque affectant les infections à otomycose humaine. Turk. J. Med. Sci. 2015, 45, 820–826. [Google Scholar] [CrossRef] [PubMed]
  26. Garcia-Martos, P.; Delgado, D.; Marrin, P.; Mira, J. Analysis of 40 cases of otomycosis. Enfermedades Infecc. Microbiol. Clínica 2005, 11, 487–489. [Google Scholar]
  27. Vennewald, I.; Klemm, E. Otomycosis: Diagnosis and treatment. Clin. Dermatol. 2010, 28, 202–211. [Google Scholar] [CrossRef]
  28. Gharaghani, M.; Seifi, Z.; Mahmoudabadi, A.Z. Otomycosis in Iran: A Review. Mycopathologia 2015, 179, 415–424. [Google Scholar] [CrossRef]
  29. Sangaré, I.; Amona, F.M.; Ouedraogo, R.W.-L.; Zida, A.; Ouedraogo, M.S. Otomycosis in Africa: Epidemiology, diagnosis and treatment. J. Med. Mycol. 2021, 31, 101115. [Google Scholar] [CrossRef]
  30. Jia, X.; Liang, Q.; Chi, F.; Cao, W. Otomycosis in Shanghai: Aetiology, clinical features and therapy. Mycoses 2011, 55, 404–409. [Google Scholar] [CrossRef]
Table 1. Demographic data of patients with otomycoses.
Table 1. Demographic data of patients with otomycoses.
CharacteristicsNumber of Patients Examined NNumber of Positive Patients n (%)Prevalence en %
n/N
p-Value
Age range (years)0.9363
[0–20]1613 (18.57)81.25
[21–40]3330 (42.86)90.90
[41–79]3125 (35.71)80.65
Not specified22 (2.86)100.00
Total8270 (100)85.37
Gender
Male3833 (47.14)86.840.7252
Female4437 (52.86)84.09
Total8270 (100)85.37
Table 2. Fungal species isolated from patients with otomycosis.
Table 2. Fungal species isolated from patients with otomycosis.
SpeciesNumberPercentage (%)
Mold
Aspergillus niger2130.00%
Aspergillus flavus1420.00%
Aspergillus sp.57.14%
Aspergillus versicolor11.43%
Rhizopus sp.11.43%
Scopulariopsis sp.11.43%
Total4361.43%
Yeasts
Candida albicans/Candida dubliniensis710.00%
Candida sp.710.00%
Cryptococcus sp.11.43%
Total1521.43%
Co-infections
Aspergillus niger + Candida sp.57.14%
Aspergillus flavus + Candida sp.34.28%
Aspergillus niger + Candida albicans11.43%
Aspergillus niger + Apergillus flavus11.43%
Aspergillus niger + Cryptococcus sp.11.43%
Aspergillus flavus + Cryptococcus sp.11.43%
Total1217.14%
Table 3. Clinical data of patients with otomycoses.
Table 3. Clinical data of patients with otomycoses.
Characteristics Frequency Among Patients Examined
N
Frequency of Positive Patients
n (%)
Prevalence
n/N (%)
p-Value
Lifestyle
Swimming66 (8.57)100.000.5826
Humidity2218 (25.71)81.810.7227
In-ear earphones1211 (15.71)91.600.6797
Improper cleaning4236 (51.43)85.710.9271
Presence of cotton in the external auditory canal55 (7.14)100.001
History
Allergies1514 (20.00)93.30.4508
Local antibiotic treatment1211 (15.71)91.60.6839
Ear trauma53 (4.29)600.1531
Diabetes44 (5.71)1001
Prolonged corticosteroid therapy22 (2.86)1001
HIV infection22 (2.86)1001
Otologic surgery22 (2.86)1001
Traditional medicine22 (2.86)1001
No significant medical history3830 (42.86) 0.1265
Symptomatology
Otalgia4942 (60.00)85.711
Otorrhea2615 (21.43)57.705.3389 × 10−9
Hypoacusis3228 (40.00)87.500.7572
Ear pruritus5151 (72.86)1001.7033 × 10−6
Tinnitus1814 (20.00)77.700.4490
Fever43 (4.29)750.4757
Autophony11 (1.43)1001
Headache11 (1.43)1001
Not specified87 (10.00)87.50
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Diop, A.; Younes, H.; Diop, P.S.; Diallo, K.; Sambou, Y.; Diongue, K.; Ndiaye, M.; Coly, M.N.; Sarr, H.; Diom, E.S.; et al. Epidemiological Profile of Otomycosis at the Peace Hospital of Ziguinchor (Senegal). J. Fungi 2025, 11, 218. https://doi.org/10.3390/jof11030218

AMA Style

Diop A, Younes H, Diop PS, Diallo K, Sambou Y, Diongue K, Ndiaye M, Coly MN, Sarr H, Diom ES, et al. Epidemiological Profile of Otomycosis at the Peace Hospital of Ziguinchor (Senegal). Journal of Fungi. 2025; 11(3):218. https://doi.org/10.3390/jof11030218

Chicago/Turabian Style

Diop, Abdoulaye, Hussein Younes, Papa Samba Diop, Kalilou Diallo, Youssouph Sambou, Khadim Diongue, Mouhamadou Ndiaye, Mame Ngoné Coly, Habibou Sarr, Evelyne Siga Diom, and et al. 2025. "Epidemiological Profile of Otomycosis at the Peace Hospital of Ziguinchor (Senegal)" Journal of Fungi 11, no. 3: 218. https://doi.org/10.3390/jof11030218

APA Style

Diop, A., Younes, H., Diop, P. S., Diallo, K., Sambou, Y., Diongue, K., Ndiaye, M., Coly, M. N., Sarr, H., Diom, E. S., & Ndiaye, D. (2025). Epidemiological Profile of Otomycosis at the Peace Hospital of Ziguinchor (Senegal). Journal of Fungi, 11(3), 218. https://doi.org/10.3390/jof11030218

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop